Amerisource Health Services LLC is recalling 2,028 units (cartons of 30) of glipiZIDE Extended-Release Tablets (2.5 mg). This medication, used to treat type 2 diabetes, is being recalled because it failed dissolution specifications, meaning the tablets may not dissolve at the correct rate to be properly absorbed by the body. The affected product was distributed nationwide by American Health Packaging and is sold in cartons containing three 10-count unit dose blister cards.
When a medication fails to dissolve properly, it may not deliver the expected dose to the patient, potentially leading to ineffective blood sugar management. This could result in high blood sugar (hyperglycemia) for patients relying on this medication.
You have 2 options:
Quantity: 2,028 units (cartons of 30 individual unit doses)
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.